A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients

American Journal of Transplantation

Volumn 11, Issue 7, 2011, Pages 1498-1508

  Proby, C M ^a   Harwood, C A ^a   Neale, R E ^b   Green, A C ^b   Euvrard, S ^c   Naldi, L ^d   Tessari, G ^e   Feltkamp, M C W ^f   De Koning, M N C ^g   Quint, W G V ^g   Waterboer, T ^f   Pawlita, M ^f   Weissenborn, S ^h   Wieland, U ^g   Pfister, H ⁱ   Stockfleth, E ^j   Nindl, I ^j   Abeni, D ^k   Schegget, J Ter ^g   Bouwes Bavinck, J N ^f  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d Ospedale Civile Maggiore ^*  (United Kingdom)

^e UNIVERSITY HOSPITAL OF VERONA   (Italy)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g DDL DIAGNOSTIC LABORATORY   (Netherlands)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

more..

Author keywords

Betapapillomavirus; case control study; cutaneous squamous cell carcinoma; organ transplant recipient

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BETAPAPILLOMAVIRUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA VIRUS INFECTION; EYEBROW; FEMALE; GENOTYPE; GRAFT RECIPIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; BETAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, VIRAL; EUROPE; EYEBROWS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SKIN NEOPLASMS; TRANSPLANTS;

EID: 79959833206     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03589.x     Document Type: Article

References (57)

1. Lindelöf B, Sigurgeirsson B, Gäbel H, Stern RS,. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-519.
2. Jenson AO, Svaerke C, Farkas D, Pedersen L, Kragballe K, Sorensen HT,. Skin cancer risk among solid organ recipients: A nationwide cohort study in Denmark. Acta Derm Venereol 2010; 90: 474-479.
3. Birkeland SA, Storm HH, Lamm LU, et al,. Cancer risk after renal transplantation in the Nordic countries 1964-1986. Int J Cancer 1995; 60: 183-189.
4. Penn I,. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998: 147-158.
5. Adami J, Gäbel H, Lindelöf B, et al,. Cancer risk following organ transplantation: a nation-wide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227. (Pubitemid 37363407)
6. Vajdic CM, McDonald SP, McCredie MR, et al,. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831. (Pubitemid 44969182)
7. Orth G,. Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? J Invest Dermatol 2005; 125: xii-xiii. (Pubitemid 40981415)
8. Pfister H,. Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003; 31: 52-56.
9. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J,. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-2096. (Pubitemid 30414320)
10. Harwood CA, Surentheran T, McGregor JM, et al,. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-297. (Pubitemid 30368527)
11. Mackintosh LJ, de Koning MN, Quint WG, et al,. Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol 2009; 161: 56-62.
12. Bouwes Bavinck JN, Neale RE, Abeni D, et al,. Multicenter Study of the Association between Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma. Cancer Res 2010; 70: 9777-9786.
13. Purdie KJ, Surentheran T, Sterling JC, et al,. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 2005; 125: 98-107. (Pubitemid 40981430)
14. Dang C, Koehler A, Forschner T, et al. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br J Dermatol 2006; 155: 129-136. (Pubitemid 43876405)
15. Weissenborn SJ, Nindl I, Purdie K, et al,. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125: 93-97. (Pubitemid 40981429)
16. Schulz TF,. Cancer and viral infections in immunosuppressed individuals. Int J Cancer 2009; 125: 1755-1763.
17. Caldeira S, Zehbe I, Accardi R, et al,. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 2003; 77: 2195-2206. (Pubitemid 36110032)
18. Massimi P, Thomas M, Bouvard V, et al,. Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology 2008; 371: 374-379. (Pubitemid 351173231)
19. Bedard KM, Underbrink MP, Howie HL, Galloway DA,. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol 2008; 82: 3894-3902. (Pubitemid 351521226)
20. Gabet AS, Accardi R, Bellopede A, et al,. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J 2008; 22: 622-632. (Pubitemid 351225598)
21. Westphal K, Akgul B, Storey A, Nindl I,. Cutaneous human papillomavirus E7 type-specific effects on differentiation and proliferation of organotypic skin cultures. Cell Oncol 2009; 31: 213-226.
22. Jackson S, Storey A,. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000; 19: 592-598. (Pubitemid 30099373)
23. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA,. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 2008; 82: 10408-10417. (Pubitemid 352691188)
24. Iftner T, Elbel M, Schopp B, et al,. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J. 2002; 21: 4741-4748. (Pubitemid 34984361)
25. Giampieri S, Storey A,. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 2004; 90: 2203-2209. (Pubitemid 38869731)
26. Akgül B, Cooke JC, Storey A,. HPV-associated skin disease. J Pathol 2006; 208: 165-175. (Pubitemid 43126110)
27. Akgül B, Garcia-Escudero R, Ghali L, et al,. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res 2005; 65: 2216-2223. (Pubitemid 40490130)
28. Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H, Pfister HJ,. Expression of membrane type 1 matrix metalloproteinase in papillomavirus- positive cells: Role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 2005; 86: 1291-1296. (Pubitemid 40613245)
29. Schaper ID, Marcuzzi GP, Weissenborn SJ, et al,. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005; 65: 1394-1400. (Pubitemid 40270167)
30. Marcuzzi GP, Hufbauer M, Kasper HU, Weissenborn SJ, Smola S, Pfister H,. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 2009; 90: 2855-2864.
31. Hufbauer M, Lazic D, Akgul B, Brandsma JL, Pfister H, Weissenborn SJ,. Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice. Virology 2010; 403: 128-136.
32. Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A,. The Nambour Skin Cancer Prevention Study Group. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer. 2000; 86: 118-121. (Pubitemid 30133996)
33. Boxman IL, Russell A, Mulder LH, Bavinck JN, ter Schegget J, Green A,. Collaborators of the Nambour Prevention Study. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol. 2001; 117: 1108-1112. (Pubitemid 34205905)
34. Forslund O, Iftner T, Andersson K, et al,. Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196: 876-883. (Pubitemid 47378937)
35. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG,. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74: 11636-11641. (Pubitemid 32222312)
36. de Koning MN, Quint W, Struijk L, et al,. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006; 44: 1792-1800. (Pubitemid 43726271)
37. de Koning MN, Struijk L, Bouwes Bavinck JN, et al,. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007; 88: 1489-1495. (Pubitemid 46723231)
38. Harwood CA, Surentheran T, Sasieni P, et al,. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150: 949-957. (Pubitemid 38903528)
39. Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J, Forslund O,. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 2007; 127: 116-119. (Pubitemid 46005668)
40. Boxman IL, Berkhout RJ, Mulder LH, et al,. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108: 712-715. (Pubitemid 27192341)
41. de Koning MN, Weissenborn SJ, Abeni D, et al,. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 2009; 90: 1611-1621.
42. Waterboer T, Neale R, Michael KM, et al,. Antibody responses to 26 skin Human Papillomavirus types in The Netherlands, Italy and Australia. J Gen Virol 2009; 90: 1986-1998.
43. Mallitt KA, O'Rourke P, Bouwes Bavinck JN, et al., EPI-HPV-UV-CA Group. An analysis of clustering of betapapillomavirus antibodies. J Gen Virol 2010; 91: 2062-2067.
44. Feltkamp MCW, de Koning MNC, Bavinck JNB, ter Schegget J,. Betapapillomaviruses: Innocent bystanders or causes of skin cancer. J Clin Virol 2008; 43: 353-360.
45. Michael KM, Waterboer T, Sehr P, et al,. Seroprevalence of 34 human papillomavirus types in the German general population. Plos Pathogens 2008; 4: e1000091.
46. Feltkamp MC, Broer R, di Summa FM, et al,. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003; 63: 2695-2700. (Pubitemid 36605215)
47. Masini C, Fuchs PG, Gabrielli F, et al,. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003; 139: 890-894. (Pubitemid 36898924)
48. Struijk L, Hall L, Van Der ME, et al,. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 529-535.
49. Casabonne D, Michael KM, Waterboer T, et al,. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 1862-1868. (Pubitemid 47417308)
50. Bouwes Bavinck JN, Euvrard S, Naldi L, et al,. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: A case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127: 1647-1656. (Pubitemid 46933435)
51. Waterboer T, Sehr P, Michael KM, et al,. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005; 51: 1845-1853. (Pubitemid 41368175)
52. Karagas MR, Waterboer T, Li Z, Nelson HH, et al,. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: Population based case-control study. BMJ 2010; 341: c2986.
53. Antonsson A, Green AC, Mallitt KA, et al,. Prevalence and stability of antibodies to 37 human papillomavirus types-a population-based longitudinal study. Virology 2010; 407: 26-32.
54. Rothman KJ,. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46. (Pubitemid 20255621)
55. Savitz DA, Olshan AF,. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol 1995; 142: 904-908.
56. Waterboer T, Neale R, Michael KM, et al,. Antibody responses to 26 human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 2009; 90: 1986-1998.
57. Weissenborn SJ, de Koning MNC, Wieland U, Quint WGV, Pfister HJ,. Intrafamilial transmission and family-specific spectra of cutaneous betapapillomaviruses. J Virol 2009; 83: 811-816.